Obesity continues to be a public health problem in the general population, and also
significantly increases the risk for the development of new-onset heart failure (HF). However …

The administration of loop diuretics to achieve decongestion is the cornerstone of therapy for
acute heart failure. Unfortunately, impaired response to diuretics is common in these …

Context It is uncertain whether intensified heart failure therapy guided by N-terminal brain
natriuretic peptide (BNP) is superior to symptom-guided therapy. Objective To compare 18 …

Hyponatremia frequently poses a therapeutic challenge in acute decompensated heart
failure (ADHF). Treating physicians should differentiate between depletional versus …

Obesity is a growing public health problem in the general population, and significantly
increases the risk for the development of new-onset heart failure (HF). However, in the …

Heart failure is one of the leading causes of hospitalizations in the United States.
Concomitant and significant renal dysfunction is common in patients with heart failure …

Objectives: The goal of this study was to explore the association between changes in B-type
natriuretic peptide (BNP) and N-terminal pro–B-type natriuretic peptide (NT-proBNP) plasma …

Cardiovascular disease is the leading cause of premature mortality in the developed world,
and hypertension is its most important risk factor. Controlling hypertension is a major focus …

Dietary sodium restriction is arguably the most frequent self-care behavior recommended to
patients with heart failure (HF) 1, 2 and is endorsed by all HF guidelines. 2–10 However, the …

Studies have shown that patients with compensated heart failure (HF) receiving high diuretic
doses associated with normal sodium diet and fluid intake restrictions demonstrated …